By Jeane MacIntosh New York Post
NEW YORK
An American couple whose infant daughter died last year during
a routine heart operation is trying to bring her back to life
through cloning.
In a move
that makes skeptical scientists shudder, the parents are spending
$500,000 to have a new baby cloned from preserved skin cells of
the 10-month-old girl.
Adding to
the eerie scenario, the cloning will be carried out by a company
with ties to a religious cult that believes humans were cloned
by extraterrestrials.
"We anticipate
we'll start work on human cells soon, and hope to have the first
embryo ready by early this year," says Dr. Brigitte Boisselier,
scientific director for Clonaid, a biotech firm affiliated with
the Raelian religion, which believes cloning is the key to eternal
life.
"I would
love it if they were able to have the baby by Christmas,"
she says.
The couple
who are in their 30s, are still able to conceive a baby
naturally and have other young children declined to be
interviewed.
That's understandable,
since their plan has touched off a storm of controversy. Some
doctors and scientists say we are years away from having the techniques
needed for human cloning.
For others,
this is an ethical nightmare. They openly fear that by making
human replicas, we could be crossing the threshold to the Brave
New World of the social engineering of people.
"Human
cloning is very much frowned upon," concurs Dr. Russell Foulk,
medical director at the Nevada Center for Reproductive Medicine.
"Both ethically and medically, there's no reason for it
it's pointless. There are plenty of reproductive methods that
are far easier and more viable."
"It's
medically naive to think that cloning is going to bring a dead
child back. Cloning doesn't solve the problem of a missing child,"
adds Dr. Jamie Grifo, director of the division of reproductive
endocrinology and infertility at New York University Medical School.
"It's
premature to even try cloning at this point, and I don't know
of any reputable reproductive specialist who would consider it."
Boisselier
a French-born, Montreal-based scientist with a PhD in physical
and biomolecular chemistry and a mother of three brushes
such criticism aside.
So do many
others. Since Clonaid announced its plan in September, the company
has been swamped with requests from infertile couples, gay couples
and people who've lost an older child, Boisselier says.
"Twenty
years ago, when they started working with in-vitro fertilization,
there was controversy and protests from people who said those
doctors were playing God," she says. "Now, IVF is not
only acceptable, it's commonplace. Historically, people are always
afraid whenever someone introduces something new."
Boisselier
is a longtime member of the Raelians, a cult founded in 1973 by
Claude Vorilhon, a former French sportswriter who uses the name
Rael and believes humans were cloned by a group of alien scientists
from another planet. The cult claims to have 50,000 members worldwide.
Rael, who
lives in the province of Quebec, founded Clonaid in 1997 with
a group of investors called Valiant Venture Ltd. The company is
incorporated in the Bahamas and has a Web site, Clonaid.com.
Clonaid spokeswoman
Nadine Gary, who is based in Nevada, says the company has about
a dozen employees, but refuses to say where its headquarters are
located.
The couple
who want to clone their dead daughter are not Raelians, Boisselier
says. But they are wealthy, and reportedly jumped at the chance
to participate in and finance the Clonaid project.
"After
their baby died, they talked to many doctors and scientists, and
then they heard about Clonaid," Boisselier says.
The couple
provided the initial $500,000 Clonaid says it needed to begin
the cloning experiment. Future participants will be charged $200,000.
Boisselier
says the cloning will be done in the United States by a Clonaid
team consisting of a doctor who specializes in in-vitro fertilization,
a biochemist, a cell-fusion expert and a geneticist.
She declined
to identify the four and refused to reveal the state where the
cloning will take place, except to say it is not Nevada.
Cloning using
private funds is not illegal in the U.S., but the Food and Drug
Administration says it has the authority to regulate and approve
any cloning project.
The agency's
Health and Human Services Department says any group seeking to
clone a human being must apply for permission and probably
won't get it because of "major unresolved safety questions."
Boisselier
says she won't contact the FDA because she doesn't believe the
agency has authority over the Clonaid project.
To clone the
child, the team plans to use the process of somatic cell nuclear
transfer the same process used to create Dolly the sheep,
the first successful animal clone, in 1996, Boisselier says.
Scientists
use an electrical shock to fuse a skin cell from an animal
in this case the dead child and clone it to an egg cell
that has had its genes removed.
The newly
combined cell grows into an embryo that's a genetic replica of
the skin-cell donor, and the embryo is planted in the uterus of
a surrogate mother to develop.
The parents
had preserved some of their dead daughter's cells "for research,"
Boisselier says.
"Our
hope is for parents to think about preserving the cells of their
loved ones before they die, to make the task of cloning easier,"
she says.
Clonaid says
on its Web site that for a cost of up to $50,000, it will take
cell samples from clients and preserve them in "a safe, confidential
place under cryogenic temperature" for future use.
It also says
it is mulling a Clonapet service for "wealthy individuals
who wish to see their lost pet brought back to life."
Even if Clonaid's
plan makes them wince, most experts say that recent scientific
advances make it a fairly safe bet that human cloning can eventually
be achieved and probably sooner than later.
What's more,
they say cloning might be easier in humans than in animals because
much more is known about human reproduction.
In 1998, Advanced
Cell Technology, a Massachusetts biotech firm, announced that
in 1995, it had successfully taken a human cell and inserted it
into a cow's egg. The egg was destroyed before it became a human
clone.
The main problem
with cloning is that most clone pregnancies end in spontaneous
abortion. For example, Dolly the sheep was the only survivor of
347 embryos.
However, scientists
believe that if a human clone survived the fetal development phase,
it would probably go on to be completely normal.
Boisselier
acknowledges there could be a high miscarriage rate, and has lined
up 50 volunteers including her own 22-year-old daughter,
Marina Cocolios to act as surrogates.
"I am
very sure about what I'm doing," says Cocolios, a fine-arts
student at a Canadian college. "These people want this baby
so much. They want the DNA of that first baby to have the chance
to fully express itself, and I want to help give that chance."
Neither the
American Medical Association nor the American Society for Reproductive
Medicine endorses human cloning. Both have called for more extensive
study into the safety and ethical issues.
The groups
do support cloning-related and embryonic research, however, because
it could lead to breakthroughs in treating or wiping out genetic
and degenerative diseases, cancer and other illnesses.
Grifo and
Foulk are far more outspoken about the matter.
"Nature
has made clones they're called identical twins. And even
identical twins don't have the same personalities, the exact same
life experiences," Grifo says.
"They
share many similar traits, but they are different. These people
think they'll replace their daughter by cloning her. They won't."
"There's
bound to be a tremendous psychological impact on a child,"
says Foulk. "If you clone a child as a replacement for one
that has died, the parents might have high expectations that it
be exactly the same, and that's unfair. Even little, everyday
things the new child might walk at a later age, or be potty
trained later could put unnecessary pressure on the child.
"A cloned
child would grow up in a completely different set of circumstances
in terms of time and space. The only thing similar would be the
genetic makeup."
Boisselier
says the parents "know perfectly well there are psychological
and emotional issues, and are prepared to deal with them. People
say there will be a burden on this child. But this is a child
who is desired, who will be loved. That's a wonderful way to come
into life."
"If we
fail at this, we fail," she adds. "If someone else does
it before us, that's fine. For us, this project is philosophical,
a way to create eternal life."
Not so, says
Foulk.
"Cells
have a certain duplicative number, or life span if you
clone a cell over and over and over, it eventually runs out of
chromosomes. By the 50th time, it'll die. So this idea that you
can perpetuate a cell's life indefinitely and achieve eternal
life is just wrong."
|